This inventor holds 15 USPTO granted patents and 1 EPO patent. Top assignees: Viron Therapeutics, Inc., Robarts Research Institute, The John P. Robarts Institute. Active years: 1998-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Edmonton, CA (1998)
- London, CA (2002 - 2012)
- Gainesville, FL (US) (2012 - 2018)
Company Filing History:
9 out of 15 
4 out of 13 
1 out of 1 
Years Active: 1998-2018
Title: Grant McFadden: Pioneering Advances in Cancer Treatment
Introduction
Grant McFadden, based in London, Canada, is a prominent inventor known for his significant contributions to the field of cancer therapeutics. With a total of 15 patents to his name, McFadden has been instrumental in developing innovative treatments that harness the potential of viruses to selectively target cancerous cells.
Latest Patents
Among his latest inventions, McFadden's groundbreaking patent involves the therapeutic use of a combination of Myxoma virus and rapamycin. This invention highlights how rapamycin enhances the Myxoma virus's ability to specifically infect cells that possess a weakened innate anti-viral response, including those unresponsive to interferon. The combination is particularly promising for treating diseases that feature these vulnerable cells, especially different types of cancer. Additionally, he has developed Myxoma virus mutants adept at targeting cancer, specifically those deficient in certain viral proteins, paving the way for advanced cancer treatments.
Career Highlights
Throughout his career, Grant McFadden has been associated with notable institutions, including Viron Therapeutics, Inc. and Robarts Research Institute. His work at these organizations has focused on leveraging viral mechanisms for therapeutic interventions, particularly in oncology. His research has led to revolutionary findings and therapeutic options that may significantly improve patient outcomes.
Collaborations
McFadden's innovative endeavors have enabled him to work alongside notable colleagues, including Alexandra Lucas and Karim Essani. Their collaborative efforts have been essential in advancing research and translating innovative ideas into practical applications that benefit cancer treatment.
Conclusion
Grant McFadden's contributions to the field of cancer treatment through his patented innovations exemplify the power of combining viral therapies with other medicinal agents. His commitment to research and development continues to inspire new avenues for therapy, demonstrating the importance of innovation in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile